These metabolic insults activate inflammatory and fibrotic pathways, including NF-κB and TGF-β signaling, resulting in mesangial expansion, glomerulosclerosis, and tubulointerstitial fibrosis. Here, TGFB1 is linked to glomerulosclerosis.